Bill113th CongressFiled Jul 31, 2014Health
H.Res. 709
Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a ''Valley of Death'' in biotechnology and life sciences funding that stifles innovation and impedes translational medical research.
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Jul 31, 2014)
Recognizes the value of biomedicine, biotechnology, and life sciences; the challenges those industries face; and ways those challenges can be addressed.
What just happenedAug 1, 2014
Referred to the Subcommittee on Health.
Who’s behind it
Rep. Vargas, Juan [D-CA-51](D-CA)Sponsor
6 cosponsors4 D2 R
6cosponsors1committees4actions11subjects
- Introduced in HouseJul 31, 2014
- Aug 1, 2014Committee
Referred to the Subcommittee on Health.
- Jul 31, 2014IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
- Jul 31, 2014IntroReferralIntro-H
Introduced in House
- Jul 31, 2014IntroReferral1000
Introduced in House